R&D investments and a narrowed focus have widened the firm's competitive advantages.
Mallinckrodt's lack of scale and weak branded business keep it from earning a moat.
After a few fits and starts, Tyco is now set to trade under three separate tickers starting July 2. Tyco International will retain the TYC ticker, Tyco Electronics will assume the TEL ticker, and Covidien , the health-care concern, will trade as COV . We'll have a separate analyst covering each; ...
The device maker's planned acquisition of Covidien will make it a force to be reckoned with.
Health-care stocks are on a tear as demand slowly returns.
With two years of stellar returns behind us, our expectations for 2013 are more muted, but some opportunities persist.
Morningstar StockInvestor editor Matt Coffina discusses recent additions to the Wide Moat Focus Index.
A group of top managers continue to keep looking for good investment opportunities, while taking full advantage of a rising (and potentially overvalued) market to book some gains.
The firm is on track to meet our full-year estimates, and our $60 per share fair value estimate and wide moat rating are intact.
We skinny down the number of holdings for this mid-50s couple who wants to make sure their ample portfolio is on the right track.